Anmed Health is a full-service clinical research site in Kendall, Miami, conducting Phase II–IV studies with an experienced bilingual team and a diverse patient population.
No unnecessary delays. No gaps in communication. Anmed Health supports sponsors and CROs through every stage of a study, from initial feasibility to final data lock.
Feasibility assessments returned within 48 hours of receiving a synopsis.
Site activation completed in weeks, not months, with parallel regulatory and contract review.
Weekly enrollment reporting and direct access to our principal investigator.
For over a decade, Anmed Health has conducted clinical studies in Kendall, Miami. Our bilingual team of experienced physicians and certified research coordinators manages every stage of a protocol — from feasibility through close-out — with the documentation quality sponsors and monitors expect.
10+ Years Conducting Clinical Research
Based in Kendall, Miami — Florida
Bilingual Team — English & Spanish
Anmed Health has run Phase II through Phase IV studies in South Florida for over a decade, supported by a bilingual team and an established patient base that keeps enrollment on schedule.
Phase II–IV Research Experience
CLIA-Certified On-Site Laboratory
Bilingual Team — English & Spanish
Major Protocol Deviations
Patients in Our Database
Years Advancing Medicine
Every protocol at our Kendall site is run under the oversight of experienced, board-certified physicians who see participants at each visit.
Internal Medicine
Dr. Jorge Ernesto Sandelis is a highly respected board-certified Internal Medicine physician, originally from Cuba and now proudly serving patients in the United States. With over a decade of clinical research experience, Dr. Sandelis brings a compassionate, patient-centered approach to adult primary care and chronic disease management.
Gastroenterology
Dr. Sarol is a board certified physician, specializing in gastroenterology, and has over 20 years experience in his field. Dr. Sarol graduated from the Universidad De Ciencias Medicas De La Habana in 1983 and went on to complete his residency at Orlando Health.
Primary Care · Principal Investigator
Dr. Giralt Yanez, MD, is a primary care doctor in Miami, FL, specializing in primary care and internal medicine (adult medicine). He graduated from Havana's Higher Institute of Medical Sciences in 1991 and has 32 years of experience. Dr. Giralt Yanez, MD, has been a Principal Investigator since 2015.
Located in Kendall, our site serves a predominantly Hispanic community, supporting sponsors in meeting representation goals for their clinical programs.
Our patient population reflects the demographics of South Florida, allowing studies to enroll participants who are often underrepresented in clinical research.
More than 14,000 patients receive care at our clinic, allowing us to identify eligible candidates efficiently during the feasibility process.
Informed consent, study visits, and follow-up are conducted in the participant's preferred language, which contributes to strong retention throughout each study.
Anmed Health has served the Kendall community for over a decade. Our dedicated research space operates separately from routine clinical care, providing a controlled environment for study visits.
Sample processing, centrifugation, and shipment handled on site.
Designed to accommodate extended visits and complex dosing schedules.
Temperature-controlled and access-restricted, with documented procedures.
A dedicated workspace for study monitors with secure record access.
Areas where we have conducted protocols and maintain an established patient base.
Our recruitment approach draws on an established patient base and a coordinated follow-up process that keeps participants engaged through study completion.
Patient records are organized by diagnosis, medication, and laboratory history, allowing our team to identify eligible candidates early in the feasibility process.
Learn moreConsent discussions, appointment reminders, and study visits are conducted in the participant's preferred language, supporting comprehension and continued participation.
Learn moreEnrollment metrics are shared with study monitors on a weekly basis, keeping sponsors informed of screening, randomization, and retention throughout the study.
Learn moreOperating under the standards sponsors require
We aim to make site selection straightforward. Once we receive a protocol synopsis, our team responds promptly with a clear assessment of fit and capacity.
Confidentiality agreement. Executed the same day it is received.
Feasibility assessment. Returned within 48 hours, based on our patient records.
Site qualification visit. Conducted on site or remotely, at your convenience.
Site activation. Regulatory, budget, and contract steps completed in parallel.
Participant experience is central to retention, and we are proud of the care our team provides at every visit.
"Highly impressed with the professionalism and care provided at this clinic. The staff is knowledgeable, compassionate, and efficient. I felt valued and well taken care of throughout my visit."
"Excellent service and professionalism. This is the second time I've been treated by them, and so has my family. I feel as comfortable as family with them. I wholeheartedly recommend them."
"Outstanding customer service! They demonstrate great professionalism and treat patients with exceptional kindness. They're always ready to answer questions and offer continuous support."
Tell us about your protocol and our team will respond with enrollment projections, start-up timelines, and confirmation of site capabilities.
Response within one business day, reviewed directly by our principal investigator.
Regulatory documents on file, including CVs, licenses, lab certifications, and training records.
Confidentiality assured, with agreements executed before protocol review.
For sponsors, CROs, and study start-up teams.
Updates from our team on clinical research, site operations, and participant care.
How site selection shapes whether study enrollment reflects the patients a therapy is intended to serve.
The role of advance chart review in improving screening efficiency and lowering per-participant cost.
How regulatory and contract turnaround at the site level affects overall program timelines.
Receive occasional updates on new therapeutic areas, site capabilities, and research news.
